Preparation and biocompatibility study of gelatin/kappa-carrageenan scaffolds
- 299 Downloads
- 19 Citations
Abstract
Novel porous scaffolds composed of gelatin/κ-carrageenan (GC) were fabricated by freeze-drying followed by chemical cross-linking with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC). The morphology of the insoluble GC sponges was examined by field emission scanning electron microscopy (FE-SEM). The porosity of the GC sponge increased with increasing kappa-carrageenan content. Implantation of a GC sponge into the subcutaneous connective tissue of Wistar rats confirmed that the scaffold was biodegradable. Fibroblasts infiltrated into the sponge matrix, and regenerated collagen in the matrix to a level of 25% at 14 days after surgery. The C-reactive protein level in the blood samples also showed a similar result. The blood and histological results show that the GC sponges have good biocompatibility and low antigenicity indicating that they would be safe and effective tissue engineering scaffolds.
Keywords
gelatin kappa-carrageenan scaffold biocompatibility tissue engineeringPreview
Unable to display preview. Download preview PDF.
References
- (1).K. G. Birukov, V. P. Shirinsky, O. V. Stepanova, V. A. Tkachuk, A. W. A. Hahn, T. J. Resink, and V. N. Smirnov, Mol. Cell. Biochem., 144, 131 (1995).CrossRefGoogle Scholar
- (2).K. Kanda and T. Matsuda, Cell Transplant, 2, 475 (1993).Google Scholar
- (3).P. Reusch, H. Wagdy, R. Reusch, E. Wilson, and H. E. Ives, Circ. Res., 79, 1046 (1996).Google Scholar
- (4).B. E. Sumpio, A. J. Banes, W. G. Link, and G. Jr. Johnson, Arch. Surg., 123, 1233 (1988).Google Scholar
- (5).M. E. Nimni, D. Cheung, B. Strates, M. Kodama, and K. Skeikh, J. Biomed. Mat. Res., 21, 741 (1987).CrossRefGoogle Scholar
- (6).Y. S. Choi, S. R. Hong, Y. M. Lee, K. W. Song, M. H. Park, and Y. S. Nam, Biomaterials, 20, 409 (1999).CrossRefGoogle Scholar
- (7).Y. S. Choi, S. R. Hong, Y. M. Lee, K. W. Song, M. H. Park, and Y. S. Nam, J. Biomed. Mater. Res., 48, 631 (1999).CrossRefGoogle Scholar
- (8).Y. S. Choi, S. B. Lee, S. R. Hong, Y. M. Lee, K.W. Song, M. H. Park, and Y. S. Nam, J. Mater. Sci-Mater. M., 11, 1 (2001).Google Scholar
- (9).S. R. Hong, S. J. Lee, J. W. Shim, Y. S. Choi, Y. M. Lee, K. W. Song, M. H. Park, Y. S. Nam, and S. I. Lee, Biomaterials, 22, 2777 (2001).CrossRefGoogle Scholar
- (10).J. S. Mao, L. G. Zhao, Y. J. Yiu, and K. D. Yao, Biomaterials, 24, 1067 (2003).CrossRefGoogle Scholar
- (11).B. Diehl-Seifert, B. Kurelec, R. K. Zahn, A. Dorn, B. Jericevic, G. Uhlenbruck, and W. E. G. Mueller, J. Cell Sci., 79, 271 (1985).Google Scholar
- (12).B. Alberts, D. Bray, J. Lewis, M. Raff, K. Roberts, and J. D. Watson, The Molecular Biology of the Cell, Garland Publishers, 1994, pp 971–990.Google Scholar
- (13).K. Tomihata, K. Burczak, K. Shiraki, and Y. Ikada, in Polymers of Biological and Biomedical Importance, S. W. Shalaby, Y. Ikada, R. S. Langer, and J. Williams, Eds., American Chemical Society Symp Series, 1994, Vol. 540.Google Scholar
- (14).S. Meier and E. D. Hay, Dev. Biol., 38, 249 (1974).CrossRefGoogle Scholar
- (15).G. O. Gey, M. Svoelis, M. Foard, and F. B. Bang, Exp. Cell. Res., 84, 63 (1974).CrossRefGoogle Scholar
- (16).K. T. Nijenhuis, Carrageenans, Thermoreversible Networks, Springer, Berlin, 1997, pp 203–252.Google Scholar
- (17).N. P. Ziats, K. M. Miller, and J. M. Anderson, Biomaterials, 9, 5 (1988).CrossRefGoogle Scholar
- (18).E. Jablonska, J. Jablonski, and W. E. Holownink, Immunol. Lett., 70, 191 (1999).CrossRefGoogle Scholar
- (19).W. S. Tillett and T. Francis, J. Exp. Med., 52, 561 (1930).CrossRefGoogle Scholar
- (20).T. J. Abernathy and O. T. Avery, J. Exp. Med., 73, 173 (1941).CrossRefGoogle Scholar
- (21).C. M. Macleod and O. T. Avery, J. Exp. Med., 73, 183 (1941).CrossRefGoogle Scholar
- (22).V. Kolb-Bachofen, Immunobiology, 183, 133 (1991).Google Scholar
- (23).M. Lelong, M. F. Renard, and V. Giraudeaux, Clin. Chim. Acta., 288, 147 (1999).CrossRefGoogle Scholar